ABCB1 and neoplasm: In summary, we have shown that, ABCB1 expression in a sub-population of cells is correlated with poorer outcome and survival, presumably reflecting a sub-set of tumours that are both chemoresistant and locally invasive across the two clinical trial cohort assessed.